Direct comparison of the psychometric properties of multiple interview and patient-rated assessments of suicidal ideation and behavior in an adult psychiatric inpatient sample

Journal of Clinical Psychiatry

Volumn 76, Issue 12, 2015, Pages 1676-1682

  Youngstrom, Eric A ^a   Hameed, Ahmad ^b   Mitchell, Michael A ^c   Van Meter, Anna R ^d   Freeman, Andrew J ^e   Algorta, Guillermo Perez ^f   White, Amanda M ^b   Clayton, Paula J ^g,h   Gelenberg, Alan J ^b   Meyer, Roger E ^b  

^a University of North Carolina at Chapel Hill   (United States)

^b PENN STATE COLLEGE OF MEDICINE   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d YESHIVA UNIVERSITY   (United States)

^e UNIVERSITY OF NEVADA   (United States)

^f LANCASTER UNIVERSITY   (United Kingdom)

^g UNIVERSITY OF MINNESOTA   (United States)

^h UNIVERSITY OF NEW MEXICO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ALGORITHM; ARTICLE; CALIBRATION; COLUMBIA SUICIDE SEVERITY RATING SCALE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; FOOD AND DRUG ADMINISTRATION; GOLD STANDARD; HOSPITAL ADMISSION; HOSPITAL PATIENT; HUMAN; INTERMETHOD COMPARISON; INTERNAL CONSISTENCY; INTERRATER RELIABILITY; INTERVIEW; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PATIENT ASSESSMENT; PRACTICE GUIDELINE; PRIORITY JOURNAL; PSYCHOLOGICAL RATING SCALE; PSYCHOMETRY; RANDOMIZED CONTROLLED TRIAL; SENSITIVITY AND SPECIFICITY; SHEEHAN SUICIDALITY TRACKING SCALE; SUICIDAL BEHAVIOR; SUICIDAL IDEATION; SUICIDE ATTEMPT; SUICIDE TRACKING SCALE; UNITED STATES; VIDEORECORDING; COMPARATIVE STUDY; DEVICES; MIDDLE AGED; PSYCHOLOGIC TEST; REPRODUCIBILITY; SEVERITY OF ILLNESS INDEX; STANDARDS; YOUNG ADULT;

ADULT; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; INPATIENTS; INTERVIEW, PSYCHOLOGICAL; MALE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; PSYCHOMETRICS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; SUICIDAL IDEATION; SUICIDE, ATTEMPTED; YOUNG ADULT;

EID: 84954305677     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.14m09353     Document Type: Article

References (46)

1. Posner K, Brown GK, Stanley B, et al. The Columbia-Suicide Severity Rating Scale: initial validity and internal consistency findings from three multisite studies with adolescents and adults. Am J Psychiatry. 2011;168(12): 1266-1277.
2. Hammad TA, Laughren TP, Racoosin JA. Suicide rates in short-term randomized controlled trials of newer antidepressants. J Clin Psychopharmacol. 2006;26(2):203-207.
3. Christman DS, Faubion MD. Suicide attempt following initiation of topiramate. Am J Psychiatry. 2007;164(4):682-683.
4. Hammad TA, Laughren T, Racoosin J. Suicidality in pediatric patients treated with antidepressant drugs. Arch Gen Psychiatry. 2006;63(3):332-339.
5. Stone M, Laughren T, Jones ML, et al. Risk of suicidality in clinical trials of antidepressants in adults: analysis of proprietary data submitted to US Food and Drug Administration. BMJ. 2009;339:b2880.
6. Kuehn BM. FDA warns of adverse events linked to smoking cessation drug and antiepileptics. JAMA. 2008;299(10):1121-1122.
7. Kalinin VV. Suicidality and antiepileptic drugs: is there a link? Drug Saf. 2007;30(2):123-142.
8. Jepsen P, Johnsen SP, Sorensen HT. Risk of suicide in users of cardiovascular drugs: a review of the epidemiological evidence. Am J Cardiovasc Drugs. 2003;3(3):163-167.
9. Sorensen HT, Mellemkjaer L, Olsen JH. Risk of suicide in users of beta-adrenoceptor blockers, calcium channel blockers and angiotensin converting enzyme inhibitors. Br J Clin Pharmacol. 2001;52(3):313-318.
10. Miller M, Swanson SA, Azrael D, et al. Antidepressant dose, age, and the risk of deliberate self-harm. JAMA Intern Med. 2014;174(6):899-909.
11. US Department of Health and Human Services, Food and Drug Administration Center for Drug Evaluation and Research (CDER), Division of Psychiatry Products. Guidance for industry: suicidality: prospective assessment of occurrence in clinical trials. Silver Spring, MD: Department of Health and Human Services; August 2010.
12. Posner K, Oquendo MA, Gould M, et al. Columbia Classification Algorithm of Suicide Assessment (C-CASA): classification of suicidal events in the FDA's pediatric suicidal risk analysis of antidepressants. Am J Psychiatry. 2007;164(7):1035-1043.
13. US Department of Health and Human Services, Food and Drug Administration Center for Drug Evaluation and Research (CDER), Division of Psychiatry Products. Guidance for industry: suicidal ideation and behavior: prospective assessment of occurrence in clinical trials. http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM225130.pdf. Published August 6, 2012. Accessed October 20, 2015.
14. Pepe MS. The Statistical Evaluation of Medical Tests for Classification and Prediction. New York, NY: Wiley; 2003.
15. Zhou X-H, Obuchowski NA, McClish DK. Statistical Methods in Diagnostic Medicine. New York, NY: Wiley; 2002.
16. Althoff RR, Rettew DC, Faraone SV, et al. Latent class analysis shows strong heritability of the child behavior checklist-juvenile bipolar phenotype. Biol Psychiatry. 2006;60(9):903-911.
17. Mahoney WJ, Szatmari P, MacLean JE, et al. Reliability and accuracy of differentiating pervasive developmental disorder subtypes. J Am Acad Child Adolesc Psychiatry. 1998;37(3):278-285.
18. Szatmari P, Volkmar F, Walter S. Evaluation of diagnostic criteria for autism using latent class models. J Am Acad Child Adolesc Psychiatry. 1995;34(2):216-222.
19. Sheehan DV, Lecrubier Y, Sheehan KH, et al. The Mini-International Neuropsychiatric Interview (MINI.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998;59(suppl 20):22-33, quiz 34-57.
20. Coric V, Stock EG, Pultz J, et al. Sheehan Suicidality Tracking Scale (Sheehan-STS): preliminary results from a multicenter clinical trial in generalized anxiety disorder. Psychiatry (Edgmont). 2009;6(1):26-31.
21. Silverman MM, Berman AL, Sanddal ND, et al. Rebuilding the tower of Babel: a revised nomenclature for the study of suicide and suicidal behaviors, part 2: suicide-related ideations, communications, and behaviors. Suicide Life Threat Behav. 2007;37(3):264-277.
22. Silverman MM, Berman AL, Sanddal ND, et al. Rebuilding the tower of Babel: a revised nomenclature for the study of suicide and suicidal behaviors, part 1: background, rationale, and methodology. Suicide Life Threat Behav. 2007;37(3):248-263.
23. Project MATCH Research Group. Matching Alcoholism Treatments to Client Heterogeneity: Project MATCH posttreatment drinking outcomes. J Stud Alcohol. 1997;58(1):7-29.
24. Harris PA, Taylor R, Thielke R, et al. Research electronic data capture (REDCap) - A metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377-381.
25. Meyer RE, Salzman C, Youngstrom EA, et al. Suicidality and risk of suicide-definition, drug safety concerns, and a necessary target for drug development: a consensus statement. J Clin Psychiatry. 2010;71(8):e1-e21.
26. McCutcheon AL. Latent Class Analysis. Thousand Oaks, CA: Sage; 1987.
27. Vermunt JK, Magidson J. Latent class cluster analysis. In: Hagenaars JA, McCutcheon AL, eds. Applied Latent Class Analysis. Cambridge, UK: Cambridge Univ Press; 2002:89-106.
28. Efron B. The Jackknife, the Bootstrap, and Other Resampling Plans. Philadelphia, PA: Society for Industrial and Applied Mathematics; 1982.
29. Hesdorffer DC, French JA, Posner K, et al. Suicidal ideation and behavior screening in intractable focal epilepsy eligible for drug trials. Epilepsia. 2013;54(5):879-887.
30. Williams JM, Anthenelli RM, Morris CD, et al. A randomized, double-blind, placebocontrolled study evaluating the safety and efficacy of varenicline for smoking cessation in patients with schizophrenia or schizoaffective disorder. J Clin Psychiatry. 2012;73(5):654-660.
31. Khan A, Khan SR, Hobus J, et al. Differential pattern of response in mood symptoms and suicide risk measures in severely ill depressed patients assigned to citalopram with placebo or citalopram combined with lithium: role of lithium levels. J Psychiatr Res. 2011;45(11):1489-1496.
32. Preti A, Sheehan DV, Coric V, et al. Sheehan Suicidality Tracking Scale (S-STS): reliability, convergent and discriminative validity in young Italian adults. Compr Psychiatry. 2013;54(7):842-849.
33. Fleiss JL. Measuring agreement between two judges on the presence or absence of a trait. Biometrics. 1975;31(3):651-659.
34. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977;33(1):159-174.
35. Cicchetti D, Bronen R, Spencer S, et al. Rating scales, scales of measurement, issues of reliability: resolving some critical issues for clinicians and researchers. J Nerv Ment Dis. 2006;194(8):557-564.
36. Kraemer HC. Evaluating Medical Tests: Objective and Quantitative Guidelines. Newbury Park, CA: Sage; 1992.
37. Silverman MM. Challenges to classifying suicidal ideations, communications, and behaviours. In: O'Connor RC, Platt S, Gordon J, eds. International Handbook of Suicide Prevention: Research, Policy and Practice. New York, NY: Wiley; 2011:9-25.
38. Kraemer HC, Lowe KK, Kupfer DJ. To Your Health: How to Understand What Research Tells Us about Risk. New York, NY: Oxford University Press; 2005.
39. Cohen J. Statistical Power Analysis for the Behavioral Sciences. 2nd ed. Hillsdale, MI: Lawrence Erlbaum; 1988.
40. Steer RA, Beck AT, Garrison B, et al. Eventual suicide in interrupted and uninterrupted attempters: a challenge to the cry-for-help hypothesis. Suicide Life Threat Behav. 1988;18(2):119-128.
41. Barber ME, Marzuk PM, Leon AC, et al. Aborted suicide attempts: a new classification of suicidal behavior. Am J Psychiatry. 1998;155(3):385-389.
42. Potkin SG, Alphs L, Hsu C, et al; InterSePT Study Group. Predicting suicidal risk in schizophrenic and schizoaffective patients in a prospective two-year trial. Biol Psychiatry. 2003;54(4):444-452.
43. Mundt JC, Greist JH, Jefferson JW, et al. Prediction of suicidal behavior in clinical research by lifetime suicidal ideation and behavior ascertained by the electronic Columbia-Suicide Severity Rating Scale. J Clin Psychiatry. 2013;74(9):887-893.
44. Jensen-Doss A, Youngstrom EA, Youngstrom JK, et al. Predictors and moderators of agreement between clinical and research diagnoses for children and adolescents. J Consult Clin Psychol. 2014;82(6):1151-1162.
45. Garb HN. Clinical judgment, clinical training, and professional experience. Psychol Bull. 1989;105(3):387-396.
46. Hughes CW. Objective assessment of suicide risk: significant improvements in assessment, classification, and prediction. Am J Psychiatry. 2011;168(12):1233-1234.